Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.

Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA; Antibacterial Resistance Leadership Group.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00464-18. doi: 10.1128/AAC.00464-18. Print 2018 Aug.

2.

Effectiveness of Probiotic for Primary Prevention of Clostridium difficile Infection: A Single-Center Before-and-After Quality Improvement Intervention at a Tertiary-Care Medical Center.

Trick WE, Sokalski SJ, Johnson S, Bunnell KL, Levato J, Ray MJ, Weinstein RA.

Infect Control Hosp Epidemiol. 2018 Jul;39(7):765-770. doi: 10.1017/ice.2018.76. Epub 2018 Apr 26.

PMID:
29695310
3.

Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae.

Bunnell KL, Wenzler E, Harrington AT, Danziger LH.

Diagn Microbiol Infect Dis. 2018 Apr;90(4):335-336. doi: 10.1016/j.diagmicrobio.2017.12.007. Epub 2017 Dec 16.

PMID:
29395714
4.

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection.

Bunnell KL, Aldossari A, Perkins C, Schriever C, Chiampas TD, Young JD, Patel MC, Badowski M.

J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325957417752261. doi: 10.1177/2325957417752261.

PMID:
29357770
5.

Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult Subjects.

Bunnell KL, Pai MP, Sikka M, Bleasdale SC, Wenzler E, Danziger LH, Rodvold KA.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02475-17. doi: 10.1128/AAC.02475-17. Print 2018 Apr.

6.

Clinical use of the polymyxins: the tale of the fox and the cat.

Wenzler E, Bunnell KL, Danziger LH.

Int J Antimicrob Agents. 2018 May;51(5):700-706. doi: 10.1016/j.ijantimicag.2017.12.023. Epub 2018 Jan 3.

PMID:
29305954
7.

Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin.

Bunnell KL, Danziger LH, Johnson S.

Open Forum Infect Dis. 2017 Apr 22;4(2):ofx078. doi: 10.1093/ofid/ofx078. eCollection 2017 Spring.

8.

Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration.

Wenzler E, Bunnell KL, Bleasdale SC, Benken S, Danziger LH, Rodvold KA.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00464-17. doi: 10.1128/AAC.00464-17. Print 2017 Jul.

9.

Methicillin-Resistant Staphylococcus aureus Pneumonia in Critically Ill Trauma and Burn Patients: A Retrospective Cohort Study.

Bunnell KL, Zullo AR, Collins C, Adams CA Jr.

Surg Infect (Larchmt). 2017 Feb/Mar;18(2):196-201. doi: 10.1089/sur.2016.115. Epub 2016 Dec 22.

PMID:
28004983
10.

Nephrotoxicity Associated with Concomitant Use of Ledipasvir-Sofosbuvir and Tenofovir in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection.

Bunnell KL, Vibhakar S, Glowacki RC, Gallagher MA, Osei AM, Huhn G.

Pharmacotherapy. 2016 Sep;36(9):e148-53. doi: 10.1002/phar.1803.

PMID:
27459733

Supplemental Content

Loading ...
Support Center